Probe will be exhibiting at “ ISICEM” in Brussels from the 20th – 24th March 2017. Neil Smith will be available all week for discussions regarding clinical evaluations, potential research projects and distribution opportunities.

Drug monitoring – Immunosuppressant Latest Update

The NanoDem project is reaching its conclusion with the successful development of a prototype analyser.  Partners met in Munich Nov 28 to Dec 1st for the final review meeting which involved assessment by the EC project officer.  Clinical evaluations will take place during the summer 2017 on receiving ethics committee approval which is expected any…
Read more »

Nanodem – Immunosuppressant monitoring

Mark O’Connell will be presenting at the forthcoming NANODEM meeting 28th Nov to Dec 1st. A proposal for ethics approval has been submitted and clinical work is planned to commence in the new year. Probe’s MicroEye forms the basis of the patient interface for the therapeutic drug monitoring project which is studying immunosuppressant levels continuously…
Read more »

ICS State of the Art 2016 (5-7 December ExCel London)

Probe will be exhibiting at the ICS State of the Art meeting in December. We will be showing our systems for continuous glucose and lactate monitoring We will be discussing the importance and practicality of automated monitoring, delivering better data without the need for constant attention. We will also be interested to hear from anyone…
Read more »